Mylan

FDA approval marks a significant milestone to help increase access and affordability of insulin for the millions of Americans…

The authority has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting…

Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.

The approval of fulphila was based on a comprehensive package of analytical, non-clinical and clinical data, which confirmed that…

The approval of Fulphila was based on a comprehensive package of analytical, nonclinical and clinical data, which confirmed that…

The FDA goal date set under the Biosimilar User Fee Act (BsUFA) is December 27, 2020 Biocon and Mylan announced that the US…

The company announced that the last supplies of the drug to the firm were made in September 2017 Amid the voluntary recall of…

Ian Read and James Kilts offer strong experience to support long-term value creation Pfizer and Mylan announced that Ian Read…

Expanded capacity will enable greater patient access globally

Formed through a combination of two complementary businesses, Viatris will unite Upjohn’s strong leadership position in China and…